Change font size Change contrast

David Fellows – Chairman

David is Chief Executive Officer of NightstaRx Ltd. He was previously Vice President of Johnson & Johnson’s Vision Care Franchise and Regional President at Allergan plc. David is Chairman of Oxular Limited and is a board member of NightstaRx Limited and the Glaucoma Foundation. Read more

Thomas Cavanagh – Director and CEO

Thomas is a co-founder, the Chief Executive Officer and a Board member of Oxular Limited. He is an experienced and successful entrepreneur who has helped to build four previous private equity-backed ventures. He was formerly co-founder and President of Aciex Therapeutics, where he brought its lead programme to NDA, oversaw development of a novel API technology which became the basis for future pipeline products and led a successful M&A transaction in 2014. View our team page

Ronald Yamamoto – Director and CSO

Ronald is a co-founder, the Chief Scientific Officer and a Board member of Oxular Limited. He brings more than 30 years of medical device and drug product development experience. Ronald has developed novel ophthalmic microcatheters for surgical treatment of glaucoma and retinal disease, sub-retinal access devices, diagnostic microspheres and drug-releasing implants. He was previously a co-founder and Chief Scientific Officer of iScience Interventional. View our team page

Nigel Pitchford – Director

Nigel is Chief Investment Officer of Touchstone Innovations plc. He was previously a partner at DFJ Esprit and 3i plc where he led and managed healthcare investments in both Europe and the US. Nigel is a board member of Oxular Limited, Touchstone Innovations plc, Abzena plc and Veryan Holdings Limited. Read more

John Illet – Director

John is Group General Counsel and Company Secretary of Consort Medical plc. He was previously Lead Counsel – Europe at Synageva Biopharma Inc. and was General Counsel and Company Secretary of LGC Group Ltd. John is a Board member of Oxular Limited. Read more

Dina Chaya – Director

Dina is a partner with NeoMed. She was previously at 3i plc in London and Index Ventures in Geneva and has worked in the private equity and venture capital healthcare industry in Europe and the US since 2001. Dina is a Board member of Oxular Limited, TopiVert Ltd and Wilson Therapeutics AB. Read more

Christina Takke – Director

Christina is co-founder and Managing Director of V-Bio Ventures. Christina was previously a partner with Forbion Capital Partners (formerly ABN AMRO Capital) where she led and managed a series of successful biotech investments since 2001. Christina is a Board member of Oxular Limited and Confo Therapeutics NV. Read more

Inga Deakin – Board Observer

Inga is a Principal on the healthcare ventures teams of Touchstone Innovations plc and specialises in investments in medical devices, therapeutics, diagnostics and digital healthcare. Inga is a Board member of Puridify and Ieso Digital Health and a Board Observer of Oxular Limited and Veryan Holdings Limited. Read more